New Strong Sell Stocks for Oct. 22

Group 1 - Atossa Therapeutics, Inc. (ATOS) is a clinical-stage biopharmaceutical company with a 4% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Bridgeline Digital, Inc. (BLIN) is a marketing technology company that has seen a 12% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Cantaloupe, Inc. (CTLP) is a digital payment and software services company with a 6.7% downward revision in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2]